IP Library Granted Patent US 10,807,869
Granted Patent B2
US 10,807,869 · App. 16/151,374 · Granted Oct 20, 2020

Method for producing porous calcium deficient hydroxyapatite granules

Inventors: Alex De Gasparo (Biel, CH); Noemie Van Garderen (Dubendorf, CH); Marc Bohner (Grenchen, CH); Howard Seeherman (Cambridge, MA); Eric Vanderploeg (Stoneham, MA)
Assignees: Mathys AG Bettlach; Bioventus, LLC
C01B25/32A61K47/02C01P2004/61C01P2006/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,807,869
App. No.
16/151,374
Granted
Oct 20, 2020
Kind
B2
Abstract

The method is for producing porous calcium deficient hydroxyapatite granules and comprises the following steps: (a) subjecting granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) to an incubation in an alkaline aqueous solution having a pH-value of less than 10 and containing PO 4 3− ions; whereby the granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) comprise interconnected pores with a minimum mean diameter of 3 microns; (b) washing with water the granules obtained after incubation of step a); (c) drying the obtained porous granules of calcium deficient hydroxyapatite; whereby (d) the amount-of PO 4 3− ions present in the incubation of step a) is at least as large as the amount of SO 4 2− ions of the granules used for step (a). The porous calcium deficient hydroxyapatite granules obtained by the invention may be purposefully used as carriers for biologically active substances in particular for proteins.

Claims (24)

1. A method for producing porous calcium deficient hydroxyapatite granules comprising the following steps:

(a) subjecting granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) to an incubation in an alkaline aqueous solution having a pH-value of less than 10 and containing PO4 3− ions; whereby the granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) comprise interconnected pores with a minimum mean diameter of 3 microns;

(b) washing with water the granules obtained after incubation of step a);

(c) drying the obtained porous granules of calcium deficient hydroxyapatite; whereby

(d) the amount of PO4 3− ions present in the incubation of step a) is at least as large as the amount of SO 4 2− ions of the granules used for step (a).

2. The method according to claim 1 , wherein the granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) used in step a) are obtained from CSD particles which have been mixed with a porogenic substance and made porous by heat treatment to decompose the porogenic substance and sintering.

3. The method according to claim 2 , wherein the majority of the CSD particles used to produce the granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) used for step a) have a needle shape.

4. The method according to claim 2 , wherein the majority of the CSD particles used to produce the granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) used for step a) have a platelet shape.

5. The method according to claim 2 , wherein the majority of the CSD particles used to produce the granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) used for step a) are a mixture of needle shaped particles and platelet shaped particles.

6. The method according to claim 2 , wherein the majority of the CSD particles used to produce the granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) used for step a) have a mean aspect ratio in the range of 2.5 to 6.0.

7. The method according to claim 2 , wherein the CSD particles used to produce the granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) used for step a) have a mean length greater than 10 μm.

8. The method according to claim 1 , wherein only granules of calcium sulfate anhydrous (CSA) are used in step (a).

9. The method according to claim 1 , wherein the alkaline aqueous solution of step (a) comprises either (NH 4 )(H 2 PO 4 ), (NH 4 ) 2 (HPO 4 ), or (NH 4 ) 3 (PO4) and either NaOH or KOH.

10. The method according to claim 1 , wherein the liquid to powder ratio in step (a) is at most 15 ml/g.

11. The method according to one of the claim 1 , wherein the incubation of step (a) is performed at a temperature from 60° C. to 100° C.

12. The method according to claim 1 , wherein step c) comprises a spray drying process.

13. The method according to claim 12 , wherein the spray drying process is controlled so as to produce spherical granules with a mean diameter below 425 μm.

14. The method according to 1 , wherein the porous granules of CSA, CSH, or CSD are obtained by first solidifying a slurry consisting of a mixture of CSA, CSH, or CSD powder and an aqueous or non-aqueous solution, and second breaking the resulting block into granules.

15. The method according to claim 1 , wherein the CSA, CSD or CSH porous granules are shaped with a high shear mixer and calcined.

16. The method according to claim 1 , wherein the drying of the obtained granules after full conversion into calcium deficient hydroxyapatite (CDHA) comprises a heating step at a temperature higher than 60° C.

17. The method according to claim 1 , wherein the porosity of the granules measured before the incubation of step a) is 40% larger than after incubation step a).

18. The method according to claim 1 , wherein the amount of PO4 3− ions present in the incubation of step a) is at least two times greater than the amount of SO 4 2− ions in the granules.

19. The method according to claim 1 , wherein the granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) used in step (a) comprise less than 1 weight % of carbon residues.

20. The method according to claim 1 , wherein the alkaline aqueous solution comprises NaOH or KOH.

Assignments (5)
SECURITY INTEREST Recorded Aug 1, 2025
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 071904/0465 →
RELEASE OF SECURITY INTEREST Recorded Aug 1, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BIOVENTUS LLC
Reel/Frame 071909/0861 →
SECURITY INTEREST Recorded Dec 13, 2019
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 051272/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2019
From: DE GASPARO, ALEX; VAN GARDEREN, NOEMIE; BOHNER, MARC
To: MATHYS AG BETTLACH
Reel/Frame 047952/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2019
From: SEEHERMAN, HOWARD; VANDERPLOEG, ERIC
To: BIOVENTUS, LLC.
Reel/Frame 048043/0570 →